Standard infection control procedures are in place that follow current Ambulance Service Association guidelines for decontaminating ambulances, with stringent cleaning procedures between patients, such as washing and wiping down areas and surfaces within the ambulance that have been in contact with the patient with detergent or alcohol spray. Single-use equipment and clinical waste would be disposed of in accordance with current procedures.
As announced by the Department on 16 August 2007, advanced supply contracts have been put in place with two companies, Baxter Healthcare and GlaxoSmithKline (GSK). The contracts allow the United Kingdom to purchase up to 120 million doses of pandemic specific vaccine should a pandemic occur. The exact number of doses will be determined by the strength of the virus and its impact on the population, which will only be known once the virus has emerged. Pandemic specific vaccines will be manufactured at Baxter Healthcare's facilities in Austria and the Czech Republic, and at GSK's site in Germany.